Matthew L. Pearn
Publications by Year
Research Areas
Anesthesia and Neurotoxicity Research, Intensive Care Unit Cognitive Disorders, Down syndrome and intellectual disability research, Alzheimer's disease research and treatments, Anesthesia and Sedative Agents
Most-Cited Works
- → Pathophysiology Associated with Traumatic Brain Injury: Current Treatments and Potential Novel Therapeutics(2016)299 cited
- → Loss of Caveolin-1 Accelerates Neurodegeneration and Aging(2010)188 cited
- → Amyloid precursor protein–mediated endocytic pathway disruption induces axonal dysfunction and neurodegeneration(2016)183 cited
- → Membrane lipid rafts and neurobiology: age‐related changes in membrane lipids and loss of neuronal function(2015)175 cited
- → Propofol Neurotoxicity Is Mediated by p75 Neurotrophin Receptor Activation(2011)141 cited
- → Isoflurane Neurotoxicity Is Mediated by p75NTR-RhoA Activation and Actin Depolymerization(2010)118 cited
- → Targeting increased levels of APP in Down syndrome: Posiphen‐mediated reductions in APP and its products reverse endosomal phenotypes in the Ts65Dn mouse model(2020)52 cited
- → An Anti-β-Amyloid Vaccine for Treating Cognitive Deficits in a Mouse Model of Down Syndrome(2016)46 cited
- → Inhibition of RhoA reduces propofol-mediated growth cone collapse, axonal transport impairment, loss of synaptic connectivity, and behavioural deficits(2018)44 cited
- → Swedish Nerve Growth Factor Mutation (NGF R100W ) Defines a Role for TrkA and p75 NTR in Nociception(2018)43 cited